3Bolos V,Grego-Bessa J,Pompa J.Notch Signaling in Development and Cancer.Endocrine Reviews,2007,28 (3):39-363.
4Teachey DT,Seif AE,Brown VI,et al.Targeting Notch signaling in autoimmune and lymphoproliferative disease.Blood,2008,VOLUME (111):705-714.
5Li J,Qu X,Bertram JF.Endothelial-myofibroblast transitioncontributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice.Am J Pathol,2009,175 (4):1380-1388.
3Margetts PJ, Kolb M, Yu L, et al. Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum. Am J Pathol, 2002,160:2285-2294.
4Biocompatibility of peritoneal dialysis solutions. Proceedings of a seminar. Seoul, Korea, 26 August 2000. Petit Dial Int, 2000,20 Suppl 5:S3-S68.
5Margetts P J, Bonniaud P, Liu L, et al. Transient overexpression of TGF-{beta} 1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol, 2005,16:425-436.
6Yanez-Mo M, Lara-Pezzi E, Selgas R, et al. Peritoneal dialysis and epithelial- to- mesenchymal transition of mesothelial cells. N Engl J Med, 2003,348:403-413.
7Yang AH, Chen JY, Lin JK. Myofibroblastic conversion of mesothelial cells. Kidney Int, 2003,63:1530-1539.
8Lewis J. Notch signalling and the control of cell fate choices in vertebrates. Semin Cell Dev Biol, 1998,9:583- 589.
9Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science, 1999,284:770-776.
10Radtke F, Raj K. The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer, 2003,3: 756-767.
